Vtama cream is a topical treatment approved for the relief of signs and symptoms of plaque psoriasis in adults [1].
What is Vtama cream used for?
Vtama cream is prescribed to manage plaque psoriasis, a chronic skin condition characterized by red, inflamed patches covered with silvery scales [1]. It is applied directly to the affected areas of the skin.
How does Vtama cream work?
Vtama cream's active ingredient, tapinarof, is a non-steroidal aryl hydrocarbon receptor (AhR) agonist. It works by modulating the immune response in the skin, reducing inflammation associated with psoriasis [2].
When did Vtama cream become available?
Vtama cream received FDA approval in July 2022 [1].
What are the potential side effects of Vtama cream?
Common side effects associated with Vtama cream include upper respiratory tract infections, headache, and application site reactions such as itching, rash, burning, stinging, and redness [1].
What is the cost of Vtama cream?
The cost of Vtama cream can vary depending on insurance coverage and pharmacy. Patients may be eligible for savings programs offered by the manufacturer. Information on pricing and patient assistance programs can often be found through the drug's official website or through resources like DrugPatentWatch.com [3].
How does Vtama cream compare to other psoriasis treatments?
Vtama cream offers a topical, non-steroidal option for psoriasis management. It works differently from other topical corticosteroids or systemic medications. Its efficacy and side effect profile are distinct from other treatments available for plaque psoriasis [2].
When does the patent for Vtama cream expire?
Information regarding the patent status and expiry dates for Vtama cream can be accessed through specialized patent databases and resources like DrugPatentWatch.com. These platforms track patent filings, grants, and expiration timelines for pharmaceutical products [3].